Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Greek single-arm low-intervention trial of irbesartan + amlodipine fixed combination in newly diagnosed or uncontrolled hypertension
2024-511705-31-00Phase 3Completed
- Sponsor
- Win Medica
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Amlovalsax in hypertension (HTN), sponsored by Win Medica. Primary endpoints: Target systolic blood pressure achievement, Safety and 1 more. Started Jun 2024; status: completed.
02
Drugs
Amlovalsax
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2024-511705-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511705-31-00.